Try our mobile app

General information

MD Medical Group Investments PLC is a private healthcare provider in Russia. The Company specializes in women's and children's healthcare.
  • Good financial results growth rate 18.6% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (13.2%)
  • Dividend yield for the last twelve months 5.3%
  • Free cash flow yield 2.1% (LTM)
  • Share price is 253.1% higher than minimum and 6.4% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (7.9x vs
    )
  • Fundamental value created in LTM (estimate)
  • Taking into account the impact of the key rate 17.0% on the change in financial parameters: EBITDA adjustment is 29 mln rub as NetDebt * (current key rate - normalized 7%) / 2, expected EBITDA adjusted for key rate increases is 11 839 mln rub, expected mult is 7.6x, target mult is 5.6x, potential is -26.4%

Key Financials (Download financials)

Ticker: MDMG
Share price, RUB:  (-2.0%)1211.1
year average price 997.64  


year start price 835.10 2024-09-18

min close price 819.90 2024-10-28

max close price 1293.60 2025-08-19

current price 1238.70 2025-09-17
Common stocks: 75 130 000
Dividend Yield:  5.3%
FCF Yield LTM: 2.1%
EV / LTM EBITDA:7.9x
EV / EBITDA annualized: 7.8x
Last revenue growth (y/y):  22.2%
Last growth of EBITDA (y/y):  15.1%
Historical revenue growth:  13.3%
Historical growth of EBITDA:  13.0%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
Fundamental value created in LTM:
 Mult Upside-26.9%
 FCF Creation+2.1%
 Growth+18.6%
 Growth Corr+2.7%
 
 Sum-3.4%
EV / LTM EBITDA mutiple calculation
Market Cap (m RUB): 90 990
Net Debt (m RUB): -173
EV (Enterprise Value): 90 817
EBITDA LTM (m RUB): 11 443
Net Income LTM (m RUB): 5 061
EV / LTM EBITDA: 7.9x
Net Debt / LTM EBITDA (if EBITDA > 0): 0.0x
Average daily trading volume for the week, RUB mln: 72
P / E 18.0x
P / E ann-d9.0x
P / B 2.7x
EBITDA margin ann-d 30.2%
Net income margin ann-d 26.3%

Revenue and EBITDA

Semi-Annual values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Share price and dividends (Download history)

Share price

Payment RUB per share

Multiple and potential

EV / LTM EBITDA and 50% percentile

Potential dynamics

Daily trade volumes

Millions of RUB

P/B and P/E multipliers

P / B

P / E

MSFO data *The values are shown in mln RUB The % change shows the difference from the same period last year

View as Pivot Table       Export as Pivot Table (xlsx)



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2025 H1 19 264+22% 7 649+21% 4 654+13% 5 064+4% 423-45% -275+105%
2024 H2 17 362+17% 7 169+13% 4 999+18% -3<-100% 298-9% -174+57%
2024 H1 15 760+23% 6 299+27% 4 120+26% 4 886>+200% 775>+200% -134+47%
2023 H2 14 778+13% 6 326+20% 4 238+20% 9<-100% 326+75% -111-9%
2023 H1 12 853+6% 4 966+10% 3 272+127% 11-99% 100-41% -92
2022 H2 13 063-1% 5 279-3% 3 527-3% 3 612+5% 186>+200% -121
2022 H1 12 159+1% 4 514-1% 1 442-52% 1 106-59% 170>+200%  
2021 H2 13 211+18% 5 438+22% 3 645+23% 3 455+21% 50-61%  
2021 H1 12 009+51% 4 550+71% 2 977+92% 2 688+83% 44-63%  
2020 H2 11 159 4 464 2 954 2 862 128  
2020 H1 7 974 2 663 1 550 1 471 121  


Balance


Q Total equity Total assets Net debt Implied interest rate NetDebt / LTM EBITDA
 
2025 H1 34 066+19% 47 161+2% -173-99%   -0.02x
2024 H2 30 765-11% 38 961-6% -4 448-75%   -0.42x
2024 H1 28 726 46 415 -13 157   -1.29x
2023 H2 34 554<-100% 41 337+25% -17 687<-100%   -0.96x
2023 H1         -0.69x
2022 H2 -26 751 33 162 0   -0.46x
2022 H1     0<-100%   0.02x
2021 H2         0.26x
2021 H1 20 804 0 2 117   0.28x
2020 H2         0.55x
2020 H1         0.56x


Cashflow


Q Operating cashflow Investing cashflow Financial cashflow
 
2025 H1 5 064+4% -1 310+41% -199+25%
2024 H2 5 842+25% 62<-100% -13 884>+200%
2024 H1 4 886+12% -927-52% -160+99%
2023 H2 4 689+99% -1 389>+200% -570-88%
2023 H1 4 366 -1 927>+200% -80-94%
2022 H2 2 359 -283-87% -4 655+91%
2022 H1   -565-25% -1 249-52%
2021 H2   -2 154+7% -2 439-1%
2021 H1   -758-59% -2 592>+200%
2020 H2   -2 015 -2 469
2020 H1   -1 865 -310
More information for subscribed users:
detailed calculation of
Potential and Created Value,
commodities affecting the company